Psychedelic Policy in Massachusetts: Where We Go from Here

Nov 7

Election Day didn’t quite go as planned for psychedelic policy reform advocates in Massachusetts, with Question 4 falling short at ballot boxes across the Commonwealth. While this result was disappointing, it’s not the end of the line for psychedelic policy reform in the state. Instead, it marks an important stepping stone in a journey that continues.

In a statement issued late Tuesday night, the Yes on 4 team expressed their gratitude to supporters and volunteers while acknowledging the setback: “While the results [weren’t] what we wanted, we made hugely important strides on this issue.” The campaign reached millions of Massachusetts residents, many of whom expressed support for making natural psychedelic substances accessible to those who don’t find relief through traditional treatments.

Despite the outcome, campaign leaders hinted at a renewed push for reform, saying, “We’ll keep fighting to find new pathways for those who struggle with mental health and look forward to working with legislators in the new session to continue advocating for access, for hope, and for healing.” The drive to provide alternative mental health solutions for Massachusetts continues with even more momentum and passion.

A Message from Dr. Hannah McLane

Dr. Hannah McLane, Founder and Director of SoundMind, shared her thoughts on the outcome, echoing the shared disappointment:

“We are deeply saddened and disappointed at the results of the vote on Tuesday night. We are grieving that people in Massachusetts who need these psychedelic therapies will not have access to them as quickly as they should and may not see access outside a traditional medical model for quite some time.”

However, Dr. McLane also highlighted that while this is a setback, SoundMind’s mission remains unchanged: “At SoundMind, we will continue to fight for all those who would deeply benefit from these profoundly effective therapies – in the Bay State and beyond.” She added an important reminder: “The use of psilocybin and many other psychedelics predates recorded human history. Thus we have history on our side. These medicines and therapies are not going anywhere.”

Additionally, in recognition of their unwavering support for psychedelic science and policy reform efforts, the SoundMind team would like to extend our deepest thanks to fellow Question 4 team and supporters including Grassroots Campaign Director Emily Oneschuk, who was the first woman Navy SEAL candidate, and fearlessly shared her personal story throughout the campaign; Dr. Franklin King of Massachusetts General Hospital (MGH); Community Engagement Director Jamie Morey; and Hollywood star known for her role in Buffy the Vampire Slayer turned-Psychedelic-Therapist Eliza Dushku—for their time and dedication to the advancement of psychedelic research and therapeutic access alike.

And another big shoutout to SoundMind alum Lieutenant Sarko Gergerian for his dedication to providing healing for first responders such as police officers, frontline healthcare workers, and Veterans.

*Dr. Hannah McLane, Lieutenant Sarko Gergerian, and Michelle Gergerian anxiously awaiting the ballot initiative results in Cambridge on Tuesday night.*

What’s Next?

While Question 4 didn’t pass, SoundMind remains dedicated to psychedelic policy advocacy and clinical services. Our efforts extend beyond Massachusetts; we’re working on state-level initiatives like New Jersey’s Psilocybin Initiative and continuing to offer ketamine-assisted psychotherapy services at our Philadelphia HQ. For those interested in learning more about these offerings, click here to learn more about our services.

The SoundMind team is unwavering in its commitment to advancing psychedelic research, policy advocacy, and clinical care. As we move forward, we’ll keep you informed about policy changes and what they mean for safe, ethical, and effective psychedelic practices. We urge our community to stay connected and stay tuned—there is much more to come.